1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 1: Characteristics of subjects with IH as part of a hemangioma syndrome compared with isolated IH
Hemangioma Syndrome (n = 42) Isolated Superficial IH (n = 53) P Value
Age (median) (IQR) (mo) 2 (3–2) 2 (3-2) .53
Female sex (%) (n) 74% (31) 86% (46) .12
Side/location of cutaneous IH (%) (n) .78
    Right face only 45% (19) 40% (21) 
    Left face only 33% (14) 41% (22) 
    Bilateral face 14% (6) 15% (8) 
    Other 7% (3) 4% (2) 
Facial segment (%) (n) 
    S1 65% (27) 30% (16) .002
    S2 50% (21) 66% (35) .14
    S3 43% (18) 28% (15) .19
    S4 21% (9) 4% (2) .010
    Multiple facial segments 57% (24) 34% (18) .037
    All facial segments 14% (6) 0% (0) .006
Intracranial IH (%) (n) 45% (19) 0% (0) <.001
Paraspinal IH (%) (n) 12% (5) 0% (0) .015
MC enlargement (%) (n) 67% (28) 0% (0) <.001
Posterior fossa abnormality (%) (n) 48% (20) 0% (0) <.001
Cardiovascular abnormalities (%) ((n) 95% (40) 0% (0) <.001
Note:—IQR indicates Interquartile range.